Oral calcium supplementation in premature and asphyxiated meonates.
Biochemical and hormonal effects of oral calcium supplementation in premature and asphyxiated neonates during the first few days of life are described. Eight pairs of infants were matched for gestational age and one-minute Apgar score. One member of each pair served as a control and the other was given supplemental oral calcium (75 mg/kg/24 hr) beginning at 12 and ending at 72 hours of age. The supplemental infants had significantly higher serum calcium values both during the time of supplementation and for 36 hours after supplementation was stopped. The oral calcium supplements had no significant effect on serum concentrations of phosphate, magnesium, 25-hydroxy-vitamin D3, or parathyroid hormone, The incidence of hypocalcemia after 12 hours of age was 0 in eight supplemented infants and three in eight control infants. In patients at risk for hypocalcemia, prospective use of oral calcium supplements during the period when there is inadequate calcium intake from feedings may prevent hypocalcemia, appears to be without deleterious effect on measurable chemical and hormonal factors important in calcium homeostasis, and results in maintenance of higher serum calcium levels after supplementation has been discontinued.
D000284:Administration, Oral; D000328:Adult; D001034:Apgar Score; D001238:Asphyxia Neonatorum / Q000188:drug therapy*; D002118:Calcium / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use*; D005260:Female; D005865:Gestational Age; D006801:Humans; D006996:Hypocalcemia / Q000517:prevention & control*; D007231:Infant, Newborn; D007234:Infant, Premature; D010281:Parathyroid Hormone / Q000097:blood; D014807:Vitamin D / Q000097:blood
D010281:Parathyroid Hormone; D014807:Vitamin D; D002118:Calcium